- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00728377
An Exercise Intervention to Prevent Gestational Diabetes
24. oktober 2016 opdateret af: Lisa Chasan-Taber, University of Massachusetts, Amherst
An Exercise Intervention to Prevent Recurrent GDM
Women diagnosed with gestational diabetes mellitus (GDM) are at substantially increased risk of developing type 2 diabetes and obesity, currently at epidemic rates in the United States.
GDM, therefore, identifies a population of women at high risk of developing type 2 diabetes and thus provides an excellent opportunity to intervene years before the development of this disorder.
It is well recognized that acute as well as chronic physical activity reduce fasting plasma glucose as well as improve glucose tolerance in type 2 diabetes.
Recent studies have suggested that women with higher levels of physical activity have reduced risk of GDM.
Therefore, we will test the hypothesis that an exercise intervention is an effective tool for preventing GDM among women with a history of GDM.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The primary goals of the application are to investigate the effects of a motivationally-tailored, individually targeted 12-wk physical activity intervention on 1) risk of GDM in women at high risk of the condition, 2) serum biomarkers associated with insulin resistance, 3) and the adoption and maintenance of exercise during pregnancy.
Secondary goals are to investigate the impact of the intervention on gestational weight gain and selected birth outcomes.
The overall goal of the intervention is to encourage pregnant women to achieve the American College of Obstetricians and Gynecologists (ACOG) Guidelines for physical activity during pregnancy (30 minutes or more of moderate- intensity activity on most days of the week) through increasing walking and developing a more active lifestyle.
The intervention draws from the theory of Stages of Motivational Readiness for Change and Social Cognitive Theory constructs for physical activity behavior and will take into account the specific social, cultural, economic, and physical environmental challenges faced by women of diverse socioeconomic and ethnic backgrounds.
The application is innovative in being the first, to our knowledge, to test a physical activity intervention designed to prevent GDM among high risk women.
The intervention protocol can readily be translated into clinical practice in underserved and minority populations.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
488
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Massachusetts
-
Springfield, Massachusetts, Forenede Stater, 01199
- Batstate Medical Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 40 år (Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
- history of gestational diabetes or overweight (>25 kg/m2) with family history of type 2 diabetes
- sedentary
Exclusion Criteria:
- history of diagnosis of diabetes, hypertension, heart disease or chronic renal disease
- current medications which adversely influence glucose tolerance
- not planning to continue the pregnancy to term
- >16 weeks gestation
- contraindications to participating in moderate physical activity
- inability to read English at a 6th grade level
- self-reported participation in >30 min of moderate or vigorous-intensity exercise on >3 days/wk
- prior participation in the study
- non-singleton pregnancy
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Dyrke motion
|
Individually Tailored (IT) Exercise Intervention This intervention is designed to increase the amount of physical activity incorporated into the daily lifestyle of pregnant women, primarily through increased walking, with the ultimate goal of achieving the American College of Obstetricians and Gynecologists (ACOG) exercise goals for pregnant women.
These goals are the same as the Surgeon General's Guidelines for physical activity for nonpregnant individuals (30 minutes or more or moderate activity on most days of the week).The intervention includes: 1) individually tailored print-based materials (i.e., individually-tailored reports and stage-matched manuals), 2) self-monitoring materials, and 3) goal setting.
|
Aktiv komparator: Heath & Wellness
|
The comparison intervention consists of a series of informational booklets published by the American College of Obstetricians and Gynecologists on general issues related to health and wellness during pregnancy.
These include alcohol and drug use during pregnancy, easing back pain, as well as the Pregnancy Fitness brochure on the safety of exercise during pregnancy.
These booklets are selected to represent high-quality, standard, low-cost, self-help material currently available to the public.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Gestational diabetes diagnosis assessed through glucose tolerance test.
Tidsramme: 28 weeks gestational age
|
28 weeks gestational age
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Maternal weight gain
Tidsramme: 40 weeks gestational age
|
40 weeks gestational age
|
Glucose
Tidsramme: 28 weeks gestational age
|
28 weeks gestational age
|
Insulin
Tidsramme: 28 weeks gestational age
|
28 weeks gestational age
|
Adiponectin
Tidsramme: 28 weeks gestational age
|
28 weeks gestational age
|
Resistin
Tidsramme: 28 weeks gestational age
|
28 weeks gestational age
|
TNF-alpha
Tidsramme: 28 weeks gestational age
|
28 weeks gestational age
|
CRP
Tidsramme: 28 weeks gestational age
|
28 weeks gestational age
|
Birth weight
Tidsramme: 40 weeks gestational age
|
40 weeks gestational age
|
Apgar score
Tidsramme: 40 weeks gestational age
|
40 weeks gestational age
|
Adoption and maintenance of exercise during pregnancy
Tidsramme: 40 weeks gestational age
|
40 weeks gestational age
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Lisa Chasan-Taber, University of Massachusetts, Amherst
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Hawkins M, Chasan-Taber L, Marcus B, Stanek E, Braun B, Ciccolo J, Markenson G. Impact of an exercise intervention on physical activity during pregnancy: the behaviors affecting baby and you study. Am J Public Health. 2014 Oct;104(10):e74-81. doi: 10.2105/AJPH.2014.302072. Epub 2014 Aug 14.
- Hawkins M, Braun B, Marcus BH, Stanek E 3rd, Markenson G, Chasan-Taber L. The impact of an exercise intervention on C - reactive protein during pregnancy: a randomized controlled trial. BMC Pregnancy Childbirth. 2015 Jun 24;15:139. doi: 10.1186/s12884-015-0576-2.
- Nobles C, Marcus BH, Stanek EJ 3rd, Braun B, Whitcomb BW, Solomon CG, Manson JE, Markenson G, Chasan-Taber L. Effect of an exercise intervention on gestational diabetes mellitus: a randomized controlled trial. Obstet Gynecol. 2015 May;125(5):1195-1204. doi: 10.1097/AOG.0000000000000738.
- Chasan-Taber L, Silveira M, Marcus BH, Braun B, Stanek E, Markenson G. Feasibility and efficacy of a physical activity intervention among pregnant women: the behaviors affecting baby and you (B.A.B.Y.) study. J Phys Act Health. 2011 Sep;8 Suppl 2(0 2):S228-38.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. juli 2007
Primær færdiggørelse (Faktiske)
1. november 2011
Studieafslutning (Faktiske)
1. november 2012
Datoer for studieregistrering
Først indsendt
2. august 2008
Først indsendt, der opfyldte QC-kriterier
2. august 2008
Først opslået (Skøn)
5. august 2008
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
26. oktober 2016
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
24. oktober 2016
Sidst verificeret
1. oktober 2016
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- DK74876
- R01DK074876 (U.S. NIH-bevilling/kontrakt)
- 1R01DK074876-01A1 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Svangerskabsdiabetes
-
xiang yangRekrutteringGestationel trofoblastisk tumor | Gestationel trofoblastisk neoplasi | Choriocarcinom | Fase I Gestational trofoblastisk tumor | Fase II Gestational trofoblastisk tumor | Fase III Gestational trofoblastisk tumor | Invasiv muldvarpKina
-
GOG FoundationNational Cancer Institute (NCI)AfsluttetHydatidiform muldvarp | Choriocarcinom | FIGO Stage I Gestational trofoblastisk tumor | FIGO Stage II Gestational trofoblastisk tumor | FIGO Stage III Gestational trofoblastisk tumorForenede Stater, Korea, Republikken, Canada, Japan, Det Forenede Kongerige
-
Azienda Ospedaliero Universitaria Maggiore della...AfsluttetKardiovaskulære abnormiteter | Lille-til-gestational alderItalien
-
Carmel Medical CenterUkendtMissed Abort | Ufuldstændig abort | Uterin Gestational Rester | Uterin arterie DopplerIsrael
-
Sansum Diabetes Research InstituteRekrutteringDiabetes mellitus, type 2 | Diabetes Mel Gestational - under graviditetForenede Stater
-
Johns Hopkins Bloomberg School of Public HealthJiVitA Project, Gaibandha, BangladeshAfsluttetFor tidlig fødsel | Fødselsvægt | Abort | Lille-til-gestational alderBangladesh
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Strasbourg, France; Centre Hospitalier Universitaire... og andre samarbejdspartnereUkendtIntrauterin vækstrestriktion | Lille-til-gestational alder
-
Assistance Publique - Hôpitaux de ParisAfsluttet
-
PfizerAfsluttetShort Statur Born Small for Gestational Age (SGA)Japan
-
International Food Policy Research InstituteAfsluttetFor tidlig fødsel | Lille-til-gestational alder | Dårlig fostervækstForenede Stater
Kliniske forsøg med Heath & Wellness
-
Yale UniversitySubstance Abuse and Mental Health Services Administration (SAMHSA)AfsluttetHiv | Præ-eksponeringsprofylakse | MændForenede Stater
-
Hadassah Medical OrganizationRekrutteringHjerte-kar-sygdomme | SundhedskompetenceIsrael